The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes.
D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D000075747:Baculoviral IAP Repeat-Containing 3 Protein; D002166:Camptothecin / Q000494:pharmacology; D061945:Caspase Inhibitors; D002478:Cells, Cultured; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000502:physiology; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000096:biosynthesis; D004789:Enzyme Activation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000235:genetics; D015603:Keratinocytes / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D044767:Ubiquitin-Protein Ligases; D054804:Cathelicidins
D023181:Antimicrobial Cationic Peptides; D061945:Caspase Inhibitors; D052246:Cyclooxygenase 2 Inhibitors; D051034:Inhibitor of Apoptosis Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; C494832:BIRC3 protein, human; D000075747:Baculoviral IAP Repeat-Containing 3 Protein; D044767:Ubiquitin-Protein Ligases; D015232:Dinoprostone; D002166:Camptothecin; D054804:Cathelicidins